Synmosa Biopharma Corporation replaced Fan, De-Quan as Independent Director of the company with Wang Chien-Jen, effective date is May 25, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.55 TWD | +0.13% | -0.25% | +2.33% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.33% | 468M | |
+38.51% | 728B | |
+33.05% | 603B | |
-6.23% | 360B | |
+18.78% | 332B | |
+1.35% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.19% | 164B |
- Stock Market
- Equities
- 4114 Stock
- News Synmosa Biopharma Corporation
- Synmosa Biopharma Corporation Announces Wang Chien-Jen as Independent Director